T1	Pharmacological_substance 9 19	Mefloquine
N1000 	Reference T1 MeSH:D015767	Mefloquine
T2	Disorder 31 44	hypoglycaemia
N1 	Reference T2 UMLS:C0020615	hypoglycaemia
T3	Disorder 50 64	cachectic AIDS
N2 	Reference T3 UMLS:C0343755	cachectic AIDS
N3 	Reference T3 UMLS:C0343755	cachectic AIDS
T4	Pharmacological_substance 75 82	Quinine
N1001 	Reference T4 MeSH:D011803	Quinine
T5	Pharmacological_substance 98 107	quinidine
N1002 	Reference T5 MeSH:D011802	quinidine
T6	Disorder 133 157	iatrogenic hypoglycaemia
N4 	Reference T6 UMLS:C0020615	iatrogenic hypoglycaemia
T9	Pharmacological_substance 239 270	anti-malarial quinine analogues
T10	Pharmacological_substance 337 347	mefloquine
N1003 	Reference T10 MeSH:D015767	mefloquine
T11	Disorder 378 391	hypoglycaemia
N5 	Reference T11 UMLS:C0020615	hypoglycaemia
T12	Pharmacological_substance 398 408	mefloquine
N1004 	Reference T12 MeSH:D015767	mefloquine
T14	Disorder 453 487	gastrointestinal cryptosporidiasis
T15	Disorder 493 507	cachectic AIDS
N6 	Reference T15 UMLS:C0343755	cachectic AIDS
N7 	Reference T15 UMLS:C0343755	cachectic AIDS
T16	Disorder 521 541	protracted diarrhoea
N8 	Reference T16 UMLS:C0473133	protracted diarrhoea
T18	Disorder 687 700	Hypoglycaemia
N9 	Reference T18 UMLS:C0020615	Hypoglycaemia
T19	Pharmacological_substance 780 790	mefloquine
N1005 	Reference T19 MeSH:D015767	mefloquine
T28	Pharmacological_substance 940 950	mefloquine
N1006 	Reference T28 MeSH:D015767	mefloquine
T33	Disorder 1045 1058	hypoglycaemia
N10 	Reference T33 UMLS:C0020615	hypoglycaemia
T34	Pharmacological_substance 1070 1080	mefloquine
N1007 	Reference T34 MeSH:D015767	mefloquine
T36	Pharmacological_substance 1096 1127	anti-malarial quinine analogues
T37	Disorder 1209 1229	protracted diarrhoea
N11 	Reference T37 UMLS:C0473133	protracted diarrhoea
T38	Pharmacological_substance 1247 1266	anti-malarial drugs
N1008 	Reference T38 MeSH:D000962	anti-malarial drugs
T39	Pharmacological_substance 1277 1287	mefloquine
N1009 	Reference T39 MeSH:D015767	mefloquine
T40	Disorder 1327 1340	hypoglycaemia
N12 	Reference T40 UMLS:C0020615	hypoglycaemia
T44	Subject 65 72	patient
T41	Pharmacological_substance 349 355	Lariam
N1010 	Reference T41 MeSH:D015767	Lariam
T24	Speculation_cue 311 331	never been described
T29	Coreferring_mention 287 291	this
T31	Subject 1175 1183	patients
T32	Disorder 1165 1174	cachectic
N13 	Reference T32 UMLS:C0006625	cachectic
T7	Subject 508 515	patient
T8	Disorder 166 193	excessive insulin secretion
T21	Subject 744 747	Rat
T46	Speculation_cue 1312 1316	risk
